SCHEMBL6797097

SCHEMBL6797097

COc1ccc(C(O[C@@H]2[C@H](OC(C)=O)[C@@H]3O[C@H]2[C@@H](C(=O)O)[C@H]3C(=O)O)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 3/20 0.40
EDNRB P24530 2/20 0.40
SLC6A1 P30531 2/20 0.37
SLC6A11 P48066 1/20 0.37
PTPN1 P18031 1/20 0.37
KIF11 P52732 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPY2R P49146 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
FABP7 O15540 1/20 0.34
FABP5 Q01469 1/20 0.34
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
CYP2D6 P10635 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6797102 1.00 EDNRA (0.40) EDNRAEDNRBSLC6A1SLC6A11PTPN1
SCHEMBL6731702 0.86 EDNRA (0.41) EDNRAEDNRBSLC6A1SLC6A11KIF11
SCHEMBL6731698 0.86 EDNRA (0.41) EDNRAEDNRBSLC6A1SLC6A11KIF11
SCHEMBL6796641 0.86 TYMP (0.35) SLC6A1SLC6A11PTPN1KIF11MEN1
SCHEMBL6791347 0.81 SLC6A1 (0.35) SLC6A1SLC6A11PTPN1KIF11MEN1
SCHEMBL6801773 0.81 PDPK1 (0.36) SLC6A1SLC6A11PTPN1KIF11KMT2A
SCHEMBL25849144 0.79 ALDH1A1 (0.36) SLC6A1SLC6A11KMT2ASMN1; SMN2LMNA
SCHEMBL6794788 0.77 SLC6A11 (0.35) SLC6A1SLC6A11PTPN1KIF11MEN1
SCHEMBL6795667 0.77 SLC6A11 (0.35) SLC6A1SLC6A11PTPN1KIF11MEN1
SCHEMBL25849145 0.77 EP300 (0.36) SLC6A1SLC6A11MEN1KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040152905-A1 Universal building blocks and support media for synthesis of oligonucleotides and their analogs ISIS PHARMACEUTICALS, INC. 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152905-A1 Universal building blocks and support media for synthesis of oligonucleotides and their analogs POLM, POLRMT, POLB EDNRA 3522/4885EDNRB 2108/4885SLC6A1 4563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.